Pyridostigmine Bromide
Who holds supplier records for Pyridostigmine Bromide? 9 organisations hold a current record for Pyridostigmine Bromide: an active US FDA Type II Drug Master File or a CEP. A further 7 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (3), Austria (1), Italy (1), United States (1) and 3 other countries (3).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Pyridostigmine Bromide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pyridostigmine-bromide
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Pyridostigmine Bromide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Maithri Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 35024 · latest filing Aug 2020
- PATHEON AUSTRIA GMBH AND CO KGAustriaCEP Company GMP cert on recordActive DMF 10593 · latest filing Nov 1993
- PROCOS SPAItalyCEP Company GMP cert on recordActive DMF 16035 · latest filing Jun 2002
- Bausch Health US LLCUnited StatesActive DMF 5505 · latest filing Jul 1984
- COHANCE LIFESCIENCES LTDIndia Company GMP cert on recordActive DMF 43788 · latest filing Mar 2026
- GLOBAL CALCIUM PRIVATE LTDIndia Company GMP cert on recordActive DMF 39637 · latest filing Mar 2024
- SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTDChinaActive DMF 39379 · latest filing Apr 2024
- GermanyCEP Company GMP cert on record
- SwitzerlandCEP Company GMP cert on record
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (5)
Certificates of Suitability on the EDQM register for Pyridostigmine Bromide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 7 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village | IN | CEP 2026-165 - Rev 00 Pyridostigmine bromide, Route code-UK | Jun 2026 | — |
| AREVIPHARMA GMBH Radebeul | DE | CEP 2008-111 - Rev 03 Pyridostigmine bromide | May 2024 | Inspected Jun 2025 Germany |
| Procos S.P.A. Cameri | IT | CEP 2009-211 - Rev 01 Pyridostigmine bromide | Nov 2023 | Inspected Oct 2025 Italy |
| HAS HEALTHCARE ADVANCED SYNTHESIS SA Biasca | CH | R1-CEP 2001-348 - Rev 04 Pyridostigmine bromide | Mar 2022 | — |
| PATHEON AUSTRIA GMBH & CO. KG Linz | AT | R1-CEP 2003-117 - Rev 03 Pyridostigmine bromide | Dec 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (7)
Organisations whose Type II DMFs for Pyridostigmine Bromide are no longer active. These show a past filing, not current supply.
Show all 7 historical records
- POLYCARBON INDUSTRIES INC DBA PCI SYNTHESISInactive DMF 15665 · filed Oct 2001
- HELSINN ADVANCED SYNTHESIS SAInactive DMF 10877 · filed Apr 1994
- United States · Inactive DMF 9216 · filed Jun 1991
- CILAG CHEMIE AGInactive DMF 9029 · filed Mar 1991
- India · Inactive DMF 8952 · filed Jan 1991
- Canada · Inactive DMF 8800 · filed Oct 1990
- Switzerland · Inactive DMF 6939 · filed Apr 1987
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Pyridostigmine Bromide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL812).
Chemical identity
- IUPAC name
- (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate bromide
- Canonical SMILES
- C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-]
- InChIKey
- VNYBTNPBYXSMOO-UHFFFAOYSA-M
- Synonyms
- Bromure de pyridostigmine, Bromuro de piridostigmina, Kalimin, Kalymin, Mestinon, Mestinon 10, Mestinon ret, NSC-679759, NSC-758435, Pyridostigmine bromide, Pyridostigmini bromidum, Regonal
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cholinesterase Inhibitor
- Mechanism of action
- Cholinesterase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Pyridostigmine Bromide?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Pyridostigmine Bromide: Maithri Laboratories Private Limited (India), PATHEON AUSTRIA GMBH AND CO KG (Austria), PROCOS SPA (Italy), Bausch Health US LLC (United States), COHANCE LIFESCIENCES LTD (India), GLOBAL CALCIUM PRIVATE LTD (India), SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTD (China) and Arevipharma GmbH (Germany), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Pyridostigmine Bromide Drug Master Files are active?
Maithri Laboratories Private Limited (DMF 35024), PATHEON AUSTRIA GMBH AND CO KG (DMF 10593), PROCOS SPA (DMF 16035), Bausch Health US LLC (DMF 5505), COHANCE LIFESCIENCES LTD (DMF 43788), GLOBAL CALCIUM PRIVATE LTD (DMF 39637) and SHANGHAI ZHONGXI SUNVE PHARMACEUTICAL CO LTD (DMF 39379). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Pyridostigmine Bromide records mean?
7 organisations have only inactive Type II DMFs for Pyridostigmine Bromide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Pyridostigmine Bromide have a European Certificate of Suitability?
Yes. 5 organisations hold a valid CEP for Pyridostigmine Bromide on the EDQM register, including MAITHRI LABORATORIES PRIVATE LIMITED Gaddapotharam Village (IN), AREVIPHARMA GMBH Radebeul (DE), Procos S.P.A. Cameri (IT), HAS HEALTHCARE ADVANCED SYNTHESIS SA Biasca (CH) and PATHEON AUSTRIA GMBH & CO. KG Linz (AT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Pyridostigmine Bromide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Pyridostigmine Bromide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.